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DJ-1, the product of familial Parkinson’s disease gene and an oncogene, is a cysteine protease which
plays a role in anti-oxidative stress reaction. In this study, we identiﬁed the recognition sequence for
DJ-1 protease by using recombinant DJ-1 and a peptide library. Protease activity of DJ-1 lacking C-
terminal a-helix (DJ-1DH9) was stronger than that of full-sized DJ-1, and the most susceptible
sequence digested by DJ-1DH9 was valine–lysine–valine–alanine (VKVA) under the optimal condi-
tions of pH 5.5 and 0 mMNaCl. Divalent ions, especially Cu2+, were inhibitory to DJ-1’s protease activ-
ity. c-abl oncogene 1 product (ABL1) and kinesin family member 1B (KIF1B) containing VKVA were
digested by DJ-1DH9.
Structured summary of protein interactions:
DJ-1 cleaves KIF1B by enzymatic study (View interaction)
DJ-1 cleaves ABLI by enzymatic study (View interaction)
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
DJ-1 was ﬁrst identiﬁed by our group as a novel oncogene that
transformed mouse NIH3T3 cells in cooperation with activated ras
[1] and was later found to be a causative gene for a familial form of
Parkinson’s disease [2]. DJ-1 has multiple functions, including tran-
scriptional regulation [3–6], anti-oxidative stress function [7–9],
mitochondrial regulation [8,10–12], and functions as a chaperone
[13] and protease [14–16]. The structure of DJ-1 is similar to that
of cysteine protease from Pyrococcus horikoshii, but C-terminal a-
helix 9 blocks a catalytic domain of protease [17]. DJ-1 is cleaved
at the C-terminal region under oxidative stress conditions in vitro
and in cells [16,18], and a C-terminally cleaved form of DJ-1 en-
hances cytoprotective action against oxidative stress-induced
apoptosis [16]. Transthyretin, a causative protein in familial amy-
loidotic polyneuropathy, is degraded in cells transfected with
full-sized DJ-1 and in vitro by recombinant DJ-1 lacking a-helix 9
(DJ-1DH9), and mutation of C106 in DJ-1 results in loss of its pro-
tease activity [15]. These results suggest that a-helix 9 of DJ-1 isopened in cells by oxidative stress that causes pathological phe-
nomena such as neurodegenerative diseases. Identiﬁcation of the
recognition sequence of DJ-1 protease and of the protein(s) that
opens a-helix 9 of DJ-1 in cells will lead to elucidation of the phys-
iological role of DJ-1 protease.
In this study, we identiﬁed the recognition sequence of DJ-1 by
using recombinant DJ-1DH9 and a peptide library, and c-abl onco-
gene 1 product (ABL1) and kinesin family member 1B (KIF1B) were
digested by DJ-1DH9.
2. Materials and methods
2.1. Plasmids and puriﬁcation of DJ-1
Plasmids harboring GST-tagged wild-type DJ-1, C106S DJ-1, DJ-
1DH9 and C106S DJ-1DH9 were described previously [15]. GST-
tagged DJ-1s were expressed in and puriﬁed from Escherichia coli
and digested with PreScission protease (GE Bioscience, Little Chal-
font, UK) to cleave off GST as described previously [15] To construct
deletion mutants lacking VKVA sequences of ABL1 and KIF1B, fol-
lowing PCR primers were used. ABL1DVKVA-S: 50-GGAGA
ACCACTTGGATTTTGGCCTGAGC-30, ABL1DVKVA-AS: 50-GCTCAGGC-
CAAAATCCAAGTGGTTCTCC-30, KIF1BDVKVA-S: 50-GGAGCCTCAG
TCCGGGTAAGGCC-30, and KIF1BDVKVA-AS: 50-GGCCTTACCCGGA
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Fig. 1. DJ-1 mutants and FRETS-25Xaa Series. (A) Schematic drawing of recombi-
nant DJ-1s used in this study (left panel). Puriﬁed DJ-1 proteins were separated on
12% polyacrylamide gel and stained with coomassie brilliant blue (right panel). (B)
Schematic drawing of FRETS-25Xaa Series.
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pTOPO-KIF1B as templates and primers above. Resultant PCR prod-
uctsweredigestedwithDpnI andused for transformation into E. coli.
2.2. Screening of the peptides digested with DJ-1
First screening: Ten lM ﬂuorescence-quenching substrate li-
brary FRETS-25Xaa Series (Peptide Institute, Osaka, Japan) was re-
acted with 15 lg of recombinant DJ-1 in a buffer containing
0.5 mM acetate (pH 5.5) and 0.2 mM CaCl2 at 37 C for 8–21 h
and its ﬂuorescence intensity was measured using a ﬂuorometer
(GloMax, Promega, Madison, WI, USA). Second screening: Three can-
didates of DJ-1 target sequences that had been identiﬁed in the
ﬁrst screening (FRETS-25Val, FRETS-25Ile and FRETS-25Ala) were
reacted with 100 lM FRETS-25Xaa Series and 67.5 lg of DJ-1DH9
in the same buffer as above at 37 C for 8 or 7 h. Then, a ﬁnal con-
centration of 0.5 M EDTA (pH 8.1) was added to each reaction mix-
ture, and the reaction mixtures were frozen in liquid nitrogen and
subjected to LC–MS analysis to determine amino acids correspond-
ing to Yaa and Zaa sites as described previously [19].
2.3. Digestion of target protein candidates for DJ-1 protease in vitro
cDNAs encoding target proteins for DJ-1 protease were cloned
into pcDNA3. 35S-labeled proteins were then synthesized in vitro
using reticulocyte lysate of the TNT transcription–translation cou-
pled system (Promega) and reacted with 1 lg of recombinant DJ-1
in a buffer containing 0.5 mM acetate (pH 5.5) and 0.2 mM CaCl2 at
37 C for 4 h. Bovine serum albumin (BSA) as a negative control
was also reacted with 35S-labeled proteins. Labeled proteins were
then separated on SDS-containing polyacrylamide gels and visual-
ized by ﬂuorography.
2.4. Statistical analyses
Data are expressed as means ± S.E. Statistical analyses were per-
formed using the Tukey–Kramer test.
3. Results
3.1. Identiﬁcation of amino acid sequences digested by DJ-1
Since a C-terminal a-helix 9 in DJ-1 blocks the putative catalytic
region of DJ-1 protease and since we have shown that recombinant
DJ-1 lacking a-helix 9 (DJ-1DH9) digested transthyretin in vitro
and that this activity was diminished by substitution of an amino
acid from cysteine to serine at 106 (C106S) [15], 4 recombinant
DJ-1s were expressed in and puriﬁed from E. coli (Fig. 1A) and used
in this study. BSA was also used as a negative control. Fluores-
cence-quenching substrate library FRETS-25Xaa Series possesses
a ﬂuorescence group (Nma) and a quenching group (Dnp), and
Nma’s emission of ﬂorescence light is not activated by Dnp
(Fig. 1B). When peptides in the library are digested with protease,
ﬂuorescence intensity of Nma is increased, enabling measurement
of protease activity. The Xaa (P1) site contains 19 different amino
acids other than cysteine, and Yaa (P2) and Zaa (P3) sites contain
5 kinds of amino acids with different characteristics. Each Xaa ser-
ies is therefore a mixture of 25 kinds of peptides, and the whole li-
brary contains 475 kinds of peptides (Fig. 1B).
To determine amino acids in an Xaa site, FRETS-25Xaa Series
was reacted with 4 recombinant DJ-1s and BSA for 21 h and its
ﬂuorescence was measured. Results for valine (Val), isoleucine
(Ile), alanine (Ala) and proline (Pro) in the Xaa site are shown as
examples, in which Pro in the Xaa site of the peptide was not di-
gested with DJ-1 (Fig. 2A). While wild-type DJ-1, C106S DJ-1,C106SDH9 DJ-1 and BSA showed no or little protease activity
against FRETS-25Xaa Series, DJ-1DH9 digested FRETS-25Xaa Series
with Val, Ile and Ala in the Xaa sites in a time-dependent manner. A
summary of DJ-1 protease activities using various amino acids in
the Xaa sites in the library is shown in Fig. 2B. Of 19 amino acids,
Val, Ile and Ala, which are categorized into nonpolar amino acids,
in the Xaa sites of the peptide were found to be good substrates
for protease activity of DJ-1DH9. As the second screening, FRETS-
25Val, -25Ile and -25Ala were reacted with DJ-1DH9 for 4 h, and
amino acids in Yaa and Zaa of FRETS-25Val, -25Ile and -25Ala were
determined by using LC–MS. Ratio of peak area for FRETS-25Val in
MS proﬁles versus enzyme digestibility was plotted (Fig. 2C), and a
summary of all of the results is shown in Table 1. In the case of
FRETS-25Val, for instance, the order of sequence digestibility to
DJ-1DH9 is VKV > VPV > RYV > FKV > RKV. DJ-1 protease digested
the peptide bond between P1 amino acids and Ala.
3.2. Characteristics of DJ-1 protease
Biochemical characterization of DJ-1 protease was then carried
out using VKVA peptide (D-A2pr(Nma)-GVKVAFPK(Dnp)rr) as a
substrate and recombinant DJ-1s. Protease activity of DJ-1DH9 ap-
peared at pH 5.5–6.0 and disappeared at pH 7.4 and 9.5 (Fig. 3A),
indicating that a weak acidic condition is optimal. DJ-1 protease
activity was decreased in a salt-dependent manner and the con-
centration of 0 mM NaCl was maximal (Fig. 3B). Also, DJ-1 protease
did not require divalent ions such as Ca++, Mg++ and Cu++, and even
a low concentration of Cu++ diminished protease activity (Fig. 3C).
Kinetic analysis of the enzymatic reaction showed that the reaction
of DJ-1DH9 protease activity obeyed the Michaelis–Menthene for-
mula in which substrate concentration and reaction rate were
placed on horizontal and longitudinal axes, respectively (Fig. 3D).
Molecular activity and Michaelis–Menthen constant (kcat and km
values, respectively) were then calculated. The kcat value is repre-
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Fig. 2. Identiﬁcation of recognition sequences for DJ-1 protease. (A) Amino acids in the P1 site of FRETS-25Xaa Series were identiﬁed using various DJ-1s shown in Fig. 1A and
BSA. Results for Val, Ile, Ala and Pro in the P1 site are shown. (B) Summary of the results of experiments described in the legend for A. (C) Amino acids in P2 and P3 sites of
FRETS-25Val were identiﬁed as described in Materials and methods.
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Table 1
Relative hydrolysis rate of DJ-1DH9 for FRETS substrates.
FRETS-25Val FRETS-25Ile FRETS-25Ala
P3P2P1 Relative rate P3P2P1 Relative rate P3P2P1 Relative rate
VKV 100% VKI 100% VYA 100%
VPV 64 RYI 64 VKA 59
RYV 54 VPI 50 RYA 50
FKV 52 RKI 49 VPA 34
RKV 51 FKI 47 RIA 33
Digestibility of amino acids in P1, P2 and P3 sites for DJ-1DH9 protease is shown.
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2496 H. Mitsugi et al. / FEBS Letters 587 (2013) 2493–2499sented as substrate concentration/enzyme concentration x s, and
kcat of DJ-1DH9 protease was calculated to be 1.02  104 (S1)
(Fig. 3F). After the Lineweaver–Burk plot was made, km was calcu-
lated to be 40.1 lM, which is 1/105 of that of trypsin, a strong pro-
tease (Fig. 3E and F, respectively). These results indicate that
although protease activity of DJ-1DH9 is not strong, DJ-1DH9 has
biochemical characteristics for protease.
Since Pfp1, whose crystal structure is similar to that of DJ-1, is a
class of the cysteine protease and since a cysteine substitution mu-
tant of DJ-1, C106S DJ-1, lost protease activity (Fig. 2A), it isFl
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H. Mitsugi et al. / FEBS Letters 587 (2013) 2493–2499 2497thought that DJ-1DH9 is also a cysteine protease. To ascertain this,
two inhibitors for cysteine protease were reacted with DJ-1DH9. E-
64 is a speciﬁc inhibitor of cysteine protease and inhibits protease
activity of papain. N-ethylmaleimide (NEM) nonselectively inhibits
cysteine protease. As shown in Fig. 3G and H, protease activity of
DJ-1DH9 was inhibited by NEM, suggesting that, like Pfpi, DJ-
1DH9 is a cysteine protease.DJ-1
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and tyrosine hydroxylase or that play roles in pathogenesis of can-
cer such as ABL1 and of Parkinson0s disease (PD) such as LRRK2 and
in mitochondrial regulation such as KIF1B, POMC and UCP1
[3,4,7,20–27]. These proteins were synthesized in vitro using retic-
ulocyte lysates and reacted with DJ-1DH9, wild-type DJ-1and
C106SDH9. Of 14 proteins examined, only ABL1 and KIF1B were
cleaved by DJ-1DH9 but not by wild-type DJ-1and C106SDH9,
and the results for ABL1, KIF1B and HIPK1a as a negative example
are shown in Fig. 4A. When ABL1 and KIF1B were reacted with var-
ious amounts of DJ-1DH9, they were digested with DJ-1DH9 in a
dose-dependent manner (Fig. 4B). ABL1 and KIF1B possess a VKVA
sequence, the most digestible sequence for DJ-1DH9 protease, at
amino acid numbers 398 and 6 in the kinase domain and in the
motor domain, respectively (Fig. 4D). When these sites were di-
gested with DJ-1DH9, ABL1 and KIF1B should be cleaved to two
fragments with approximately 44 and 82 kDa and to those with
approximately 0.7 and 126 kDa, respectively, and sizes of cleaved
bands observed in Fig. 4A and B are well matched. A 126-kDa band
of KIF1B cleaved by DJ-1DH9 was observed on bands that appeared
in all the lanes. These bands may be translated from internal
methionine of KIF1B or bands cleaved by protease present in retic-
ulocyte lysates. The KIF1B fragment of 0.7 kDa was run through
gels and only a band with 126 kDa was observed. To conﬁrm
whether a VKVA sequence in ABL1 and KIF1B is a target sequence
for DJ-1 protease, ABL1 and KIF1B mutants lacking the VKVA se-
quence were constructed and reacted with wild-type DJ-1, DJ-
1DH9 and C106SDH9. As shown in Fig. 4C, these mutants were
not cleaved by DJ-1DH9. The reduced level of full-sized KIF1B mu-
tants lacking the VKVA sequence was reproducibly observed. This
may be due to conformational change of KIF1B mutant that re-
sulted in low translational efﬁciency. These results suggest that
ABL1 and KIF1B are candidate proteins for DJ-1 protease.
4. Discussion
In this study, we ﬁrst identiﬁed recognition sequences for DJ-1
protease and found that VKVA, VKIA and VYAA were preferentially
cleaved by DJ-1 lacking C-terminal a-helix 9 (DJ-1DH9) in vitro,
and wild-type, C10S DJ-1 and C106SDH9 DJ-1 had no or little pro-
tease activity (Figs. 1 and 2, Table 1). DJ-1DH9 protease has bio-
chemical characteristics of protease (Fig. 3), and ABL1 and KIF1B
were identiﬁed to be candidate proteins for DJ-1 protease
(Fig. 4). Preferred amino acids of the P1 site for DJ-1 protease are
Val, Ile and Ala, which are non-polar amino acids, and these phe-
nomena are similar to those for Pfpi [28]. Optimal pH for DJ-1 pro-
tease was 5.5–6.0 and its activity decreased at more alkaline pH
(Fig. 3). These results imply two possibilities: One is that DJ-1 pro-
tease works under oxidative stress conditions that induce acidic re-
gions locally in cells, and the other possibility is that DJ-1 protease
works in some organelles in which relatively low pH is maintained.
Such organelles include the endosome, lysosome, Golgi apparatus
and synaptic vesicle. Of these organelles, the lysosome contains
many proteases whose optimal pH is around 5. It is possible that
DJ-1 translocates to the lysosome to explore its protease activity
under some stress conditions. Cu++ strongly inhibited DJ-1DH9
protease activity (Fig. 3C). Cu++ is known to be a risk factor for Par-
kinson’s disease and has been reported to bind to DJ-1 [29]. It is
therefore thought that Cu++ binds to a near active site of DJ-1 pro-
tease, thereby inhibiting its activity.
ABL1 and KIF1B were identiﬁed as target proteins for DJ-1 pro-
tease (Fig. 4). ABL1 is a proto-oncogene product and works as a
non-receptor-type tyrosine kinase in cell differentiation, cell
growth and cell adhesion, and its overexpression or structural
abnormality results in onset of cancer [30]. Augmented expressionand activity have also been reported in patients with Alzheimer’s
disease and amyotrophic lateral sclerosis [31–33], and overexpres-
sion of ABL1 leads to apoptosis induction [33]. Furthermore, it has
been reported that ABL1 phosphorylates Parkin, a causative gene
product of familial Parkinson’s disease (Park 2), resulting in inacti-
vation of its ubiquitin ligase activity [34]. It is therefore possible
that DJ-1 degrades ABL1 to inhibit its kinase activity, thereby
maintaining neuroprotective activity of Parkin. KIF1B is a motor
protein belonging to the kinesin family of proteins and has two
splicing isoforms, KIF1Ba and KIF1Bb [25,35,36]. KIF1Ba and
KIF1Bb transport mitochondria in nerve cells and the endoplasmic
reticulum, respectively, and possess a VKVA sequence. It is possible
that DJ-1 inhibits mitochondrial transport through cleavage of
KIF1Ba.
We have shown that transthyretin is cleaved by DJ-1DH9
in vitro and that transthyretin is cleaved by transfection of full-
sized DJ-1 in cells [15]. Chen et al. reported that DJ-1 in dopaminer-
gic cells undergoes C-terminal cleavage in response to mild oxida-
tive stress, and a C-terminally cleaved form of DJ-1 with activated
protease activity enhances cytoprotective action against oxidative
stress-induced apoptosis [16]. These results suggest that the C-ter-
minal sequence of DJ-1 is opened under some stress conditions in
cells. Although the physiological function of DJ-1 protease is still
not known, the present ﬁndings will contribute to elucidation of
DJ-1 function against stresses.
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